We are live on ! Find out more
NERV icon

Minerva Neurosciences
NERV

68 hedge funds and large institutions have $63.2M invested in Minerva Neurosciences in 2021 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 17 increasing their positions, 26 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

171% more call options, than puts

Call options by funds: $964K | Put options by funds: $356K

1.22% less ownership

Funds ownership: 9.19% → 7.97% (-1.2%)

6% less funds holding

Funds holding: 72 → 68 (-4)

21% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 19

32% less capital invested

Capital invested by funds: $92.9M → $63.2M (-$29.7M)

35% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 26

Holders
68
Holders Change
-4
Holders Change %
-5.56%
% of All Funds
1.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
17
Reduced
26
Closed
19
Calls
$964K
Puts
$356K
Net Calls
+$608K
Net Calls Change
+$190K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$1.94M
2
Renaissance Technologies
Renaissance Technologies
New York
+$1.51M
3
NAM
Nexpoint Asset Management
Texas
+$692K
4
GCP
GSA Capital Partners
United Kingdom
+$669K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$604K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$5.18M
2
Goldman Sachs
Goldman Sachs
New York
-$2.31M
3
Wells Fargo
Wells Fargo
California
-$1.69M
4
N
Nuveen
North Carolina
-$1.65M
5
State Street
State Street
Massachusetts
-$1.24M
Name Holding Trade Value Shares
Change 		Change in
Stake
VF
51
Virtu Financial
New York
$36K +$41.4K +1,924 New
Squarepoint
52
Squarepoint
New York
$36K +$41.9K +1,947 New
SMH
53
Sanders Morris Harris
Texas
$28K – – –
GLA
54
Good Life Advisors
Pennsylvania
$23K – – –
YIH
55
Y-Intercept (HK)
Hong Kong
$23K +$27.3K +1,266 New
UBS Group
56
UBS Group
Switzerland
$22K -$44.9K -2,086 -64%
Royal Bank of Canada
57
Royal Bank of Canada
Ontario, Canada
$21K +$15.1K +701 +165%
PCM
58
Pinz Capital Management
New York
$18K +$21.3K +988 New
CAPTRUST Financial Advisors
59
CAPTRUST Financial Advisors
North Carolina
$9K +$10.8K +500 New
PAM
60
Panagora Asset Management
Massachusetts
$4K – – –
Citigroup
61
Citigroup
New York
$3K -$6.31K -293 -68%
TFM
62
TFC Financial Management
Massachusetts
$3K – – –
ASN
63
Advisory Services Network
Georgia
$2K +$2.69K +125 New
BNP Paribas Financial Markets
64
BNP Paribas Financial Markets
France
$1.34K -$10.8K -503 -87%
Wells Fargo
65
Wells Fargo
California
$1K -$1.69M -78,589 -100%
New York State Common Retirement Fund
66
New York State Common Retirement Fund
New York
$1K -$68.2K -3,167 -99%
AIM
67
Anchor Investment Management
South Carolina
$232 – – –
AllianceBernstein
68
AllianceBernstein
Tennessee
– -$538K -23,038 Closed
SO
69
STRS Ohio
Ohio
– -$393K -16,838 Closed
N
70
Nuveen
North Carolina
– -$1.65M -15,335 Closed
Charles Schwab
71
Charles Schwab
California
– -$231K -9,871 Closed
California Public Employees Retirement System
72
California Public Employees Retirement System
California
– -$176K -7,538 Closed
California State Teachers Retirement System (CalSTRS)
73
California State Teachers Retirement System (CalSTRS)
California
– -$156K -6,679 Closed
RhumbLine Advisers
74
RhumbLine Advisers
Massachusetts
– -$122K -5,219 Closed
State Board of Administration of Florida Retirement System
75
State Board of Administration of Florida Retirement System
Florida
– -$103K -4,402 Closed
1 2
3
4

NERV Hedge Fund Activity: Q2 2021 in Review

68 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q2 2021, worth a combined $63.2M — down 32% from $92.9M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of NERV and 15 opened new positions — a net loss of 4 holders — while 26 trimmed existing stakes and 17 added.

The largest buyer was Millennium Management, adding an estimated $1.94M. The largest seller was BlackRock, cutting an estimated $5.18M.

  • 68 institutional investors held Minerva Neurosciences (NERV) as of Q2 2021, down from 72 in Q1 2021.
  • Funds reported $63.2M of Minerva Neurosciences stock for Q2 2021, down 32% quarter-over-quarter.
  • 15 funds opened new Minerva Neurosciences positions in Q2 2021 and 19 closed out, a net change of -4 holders.
  • The largest Minerva Neurosciences buyer in Q2 2021 was Millennium Management, an estimated $1.94M added.
  • The largest Minerva Neurosciences seller in Q2 2021 was BlackRock, an estimated $5.18M sold.

Based on aggregated 13F filings for Q2 2021.